Forte Biosciences Inc (FBRX)

Feb 28, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat

Feb 28, 2025

Feb 25, 2025

Forte Biosciences Stock Down 20% But Insiders Still In US$92k Profit - Simply Wall St

Feb 25, 2025

Feb 24, 2025

Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews

Feb 24, 2025

Feb 23, 2025

(FBRX) On The My Stocks Page - Stock Traders Daily

Feb 23, 2025

Feb 23, 2025

Stock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 23, 2025

Feb 20, 2025

Forte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX) - Defense World

Feb 20, 2025

Feb 19, 2025

One Forte Biosciences Insider Raised Stake By 273% In Previous Year - Yahoo Finance

Feb 19, 2025

Feb 14, 2025

Best Stocks Under $20 Right Now - Benzinga

Feb 14, 2025

Feb 12, 2025

Where are the Opportunities in (FBRX) - Stock Traders Daily

Feb 12, 2025

Feb 09, 2025

Stock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 09, 2025

Feb 06, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

Feb 06, 2025

Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com

Feb 03, 2025

Feb 03, 2025

Autoimmune Biotech Forte Lines Up Strategic Presentations at Major Healthcare Investment Forums - StockTitan

Feb 03, 2025

Feb 01, 2025

(FBRX) Proactive Strategies - Stock Traders Daily

Feb 01, 2025

Jan 30, 2025

CSG Forte Wins TSG Real Transaction Metrics Awards for Second Consecutive Year - Yahoo Finance

Jan 30, 2025

Jan 25, 2025

Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia

Jan 25, 2025

Jan 25, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating - MSN

Jan 25, 2025

Jan 24, 2025

Forte Biosciences expands equity incentive plan - MSN

Jan 24, 2025

Jan 23, 2025

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Jan 23, 2025

Jan 23, 2025

Meiwu Technology (NYSE:WNW) Stock Price Down 13.2% – Here’s Why - Defense World

Jan 23, 2025

Jan 22, 2025

Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World

Jan 22, 2025

Jan 21, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia

Jan 21, 2025

Jan 21, 2025

Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire

Jan 21, 2025

Jan 11, 2025

(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 11, 2025

Jan 09, 2025

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World

Jan 09, 2025

Jan 06, 2025

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Jan 06, 2025

Dec 31, 2024

(FBRX) Technical Data - Stock Traders Daily

Dec 31, 2024

Dec 26, 2024

Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO) - Defense World

Dec 26, 2024

Dec 26, 2024

Investors Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Dec 26, 2024

Dec 21, 2024

(FBRX) Long Term Investment Analysis - Stock Traders Daily

Dec 21, 2024

Dec 20, 2024

100 cell and gene therapy leaders to watch in 2025 - Drug Discovery & Development

Dec 20, 2024

Dec 16, 2024

Why Forte Biosciences (FBRX) Stock Is Trading Lower - Benzinga

Dec 16, 2024

Dec 13, 2024

CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 8,233.3% in November - Defense World

Dec 13, 2024

Dec 13, 2024

Traders Buy Large Volume of Call Options on Quantum-Si (NASDAQ:QSI) - Defense World

Dec 13, 2024

Dec 12, 2024

Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors - The Manila Times

Dec 12, 2024

Dec 10, 2024

Trading (FBRX) With Integrated Risk Controls - Stock Traders Daily

Dec 10, 2024

Dec 05, 2024

FBRX Stock Soars to 52-Week High, Reaching $24.46 By Investing.com - Investing.com Nigeria

Dec 05, 2024

Dec 05, 2024

Forte Biosciences’ $53 Million Equity Financing - Global Legal Chronicle

Dec 05, 2024

Dec 02, 2024

Biopharma Takes on Deadly Brain Cancer After Decades of Failure - BioSpace

Dec 02, 2024

Nov 30, 2024

(FBRX) Trading Report - Stock Traders Daily

Nov 30, 2024

Nov 29, 2024

Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going - MSN

Nov 29, 2024

Nov 27, 2024

FBRX Stock Soars to 52-Week High, Reaching $21.47 - Investing.com India

Nov 27, 2024

Nov 27, 2024

FBRX Stock Soars to 52-Week High, Reaching $21.47 By Investing.com - Investing.com UK

Nov 27, 2024

Nov 25, 2024

Forte Biosciences Sets R&D Day to Showcase FB102 Autoimmune Treatment Pipeline | FBRX Stock News - StockTitan

Nov 25, 2024

Nov 22, 2024

Forte Biosciences CFO acquires $124,997 in company stock By Investing.com - Investing.com Canada

Nov 22, 2024

Nov 22, 2024

Forte Biosciences CFO acquires $124,997 in company stock - Investing.com

Nov 22, 2024

Nov 21, 2024

More than $50M raised by publicly traded drug developer - The Business Journals

Nov 21, 2024

Nov 21, 2024

Dallas' Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors - dallasinnovates.com

Nov 21, 2024

Nov 21, 2024

Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild - MSN

Nov 21, 2024

Nov 21, 2024

EDIT Stock Drops Amid Market Volatility in Biotech Sector - GuruFocus.com

Nov 21, 2024